SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

Clinical trial NCT00460798 · COMPLETED

Trial details

NCT number: NCT00460798
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2007-02-01
Primary completion: 2009-09-01
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.